13F

Stock

Cytokinetics Inc

CYTK · held by 19 managers

Reported value

$327.9M

Holders

19

+5 new · −1 exited

Holders’ est. mark

$379.9K

Price effect on 2 books still in the name

Largest holder

$195.1M

BANK OF AMERICA CORP /DE/

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BANK OF AMERICA CORP /DE/23.8M$195.1M—Held
MORGAN STANLEY5.19M$88.4M—Held
BARCLAYS PLC657.1K$22.2M$379.7KAdded$5.93M
Boxer Capital Management, LLC200K$11M—New
Hudson Bay Capital Management LP182.1K$10M—Held
GROUPAMA ASSET MANAGMENT350K$459.5K—Held
Swiss Life Asset Management Ltd5.14K$282.6K—New
Savant Capital, LLC4.21K$231.3K—New
OP Asset Management Ltd3.49K$191.6K—New
IFP Advisors, Inc458$25.2K—Held
Allworth Financial LP398$21.9K—Held
MV CAPITAL MANAGEMENT, INC.69$3.79K—Held
NEW MEXICO EDUCATIONAL RETIREMENT BOARD23.5K$1.29K—Held
Prestige Wealth Management Group LLC9$495$197Added$197
FNY Investment Advisers, LLC8.61K$473—Held
KBC Group NV3.47K$191—Held

Who left

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.